` Comparison: NYKD, ABBV - Alpha Spread

N
NYKD
vs
ABBV

Over the past 12 months, NYKD has underperformed ABBV, delivering a return of +17% compared to the ABBV's +30% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NYKD
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NYKD Intrinsic Value
HIDDEN
Show
ABBV Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
N
Nykode Therapeutics ASA
OSE:NYKD
2.466 NOK
Abbvie Inc
NYSE:ABBV
223.32 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NYKD, ABBV

NYKD
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
Nykode Therapeutics ASA
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NYKD, ABBV

NYKD
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
Nykode Therapeutics ASA
OSE:NYKD
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NYKD
0%
ABBV
71.2%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

Operating Margin

NYKD
-391.2%
ABBV
33.1%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

Net Margin

NYKD
-162.4%
ABBV
3.9%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

FCF Margin

NYKD
-518.2%
ABBV
33%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

ROE

NYKD
-9.1%
ABBV
138.5%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

ROA

NYKD
-8%
ABBV
1.7%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

ROIC

NYKD
-24.2%
ABBV
28.4%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

ROCE

NYKD
-20.9%
ABBV
20.2%
LTM 3Y Avg 5Y Avg 10Y Avg
N
Nykode Therapeutics ASA
Abbvie Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NYKD, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NYKD, ABBV

Performance Gap Between NYKD and ABBV
HIDDEN
Show

Performance By Year
NYKD, ABBV

Loading
NYKD
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NYKD to other stocks
Unlock Full Access to Alpha Spread
Create Free Account